Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.
2.

The roles of pathogen-associated molecular patterns in atherosclerosis.

Erridge C.

Trends Cardiovasc Med. 2008 Feb;18(2):52-6. doi: 10.1016/j.tcm.2007.12.003. Review.

PMID:
18308195
3.

Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.

Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):790-800. doi: 10.1161/ATVBAHA.113.303116. Epub 2014 Feb 13.

4.

CD40 signaling in vascular cells: a key role in atherosclerosis?

Mach F, Schönbeck U, Libby P.

Atherosclerosis. 1998 Apr;137 Suppl:S89-95. Review.

PMID:
9694547
5.

A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases.

Gregersen I, Holm S, Dahl TB, Halvorsen B, Aukrust P.

Expert Rev Cardiovasc Ther. 2016;14(3):391-403. doi: 10.1586/14779072.2016.1128828. Epub 2015 Dec 28. Review.

PMID:
26641944
6.

Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.

Mallika V, Goswami B, Rajappa M.

Angiology. 2007 Oct-Nov;58(5):513-22. Review.

PMID:
18024933
7.

Angiopoietin-like 4: A double-edged sword in atherosclerosis and ischemic stroke?

Xu L, Guo ZN, Yang Y, Xu J, Burchell SR, Tang J, Zhang J, Xu J, Zhang JH.

Exp Neurol. 2015 Oct;272:61-6. doi: 10.1016/j.expneurol.2015.05.020. Epub 2015 May 29.

PMID:
26033474
8.

Emerging role of adipokines as mediators in atherosclerosis.

Zhang H, Cui J, Zhang C.

World J Cardiol. 2010 Nov 26;2(11):370-6. doi: 10.4330/wjc.v2.i11.370.

9.

Discoidin domain receptors (DDRs): potential implications in atherosclerosis.

Ju GX, Hu YB, Du MR, Jiang JL.

Eur J Pharmacol. 2015 Mar 15;751:28-33. doi: 10.1016/j.ejphar.2015.01.033. Epub 2015 Feb 2. Review.

PMID:
25657115
10.

Inflammation in atherosclerosis: a cause or a result of vascular disorders?

Manduteanu I, Simionescu M.

J Cell Mol Med. 2012 Sep;16(9):1978-90. doi: 10.1111/j.1582-4934.2012.01552.x. Review.

11.

Epigenetics in atherosclerosis and inflammation.

Wierda RJ, Geutskens SB, Jukema JW, Quax PH, van den Elsen PJ.

J Cell Mol Med. 2010 Jun;14(6A):1225-40. doi: 10.1111/j.1582-4934.2010.01022.x. Epub 2010 Jan 30. Review.

12.

Obstructive sleep apnea and atherosclerosis.

Lévy P, Pépin JL, Arnaud C, Baguet JP, Dematteis M, Mach F.

Prog Cardiovasc Dis. 2009 Mar-Apr;51(5):400-10. doi: 10.1016/j.pcad.2008.03.001. Review.

PMID:
19249446
13.

Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis.

Tavakoli S, Asmis R.

Antioxid Redox Signal. 2012 Dec 15;17(12):1785-95. doi: 10.1089/ars.2012.4638. Epub 2012 Jun 11. Review.

14.

P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.

Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, Dufner B, Hoppe N, Ayata CK, Grimm M, Cicko S, Schulte L, Reinöhl J, von zur Muhlen C, Bode C, Idzko M, Zirlik A.

Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2237-45. doi: 10.1161/ATVBAHA.114.303585. Epub 2014 Aug 7.

15.

Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease.

Ward JR, Wilson HL, Francis SE, Crossman DC, Sabroe I.

Clin Exp Immunol. 2009 Jun;156(3):386-94. doi: 10.1111/j.1365-2249.2009.03886.x. Epub 2009 Mar 20. Review.

16.

[Rheumatoid arthritis, inflammation, and atherosclerosis].

Hürlimann D, Enseleit F, Ruschitzka F.

Herz. 2004 Dec;29(8):760-8. Review. German.

PMID:
15599672
17.

Psychological stress, vascular inflammation, and atherogenesis: potential roles of circulating cytokines.

Lu XT, Zhao YX, Zhang Y, Jiang F.

J Cardiovasc Pharmacol. 2013 Jul;62(1):6-12. doi: 10.1097/FJC.0b013e3182858fac. Review.

PMID:
23318990
18.

Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Tedgui A, Mallat Z.

Physiol Rev. 2006 Apr;86(2):515-81. Review.

19.
20.

Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease.

Yamashita T, Sasaki N, Kasahara K, Hirata K.

J Cardiol. 2015 Jul;66(1):1-8. doi: 10.1016/j.jjcc.2015.02.002. Epub 2015 Mar 2. Review.

Supplemental Content

Support Center